Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?

Paterson, RW; Toombs, J; Chapman, MD; Nicholas, JM; Heslegrave, AJ; Slattery, CF; Foulkes, AJ; Clark, CN; Lane, CA; Weston, PS; +4 more... Lunn, MP; Fox, NC; Zetterberg, H; Schott, JM; (2015) Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice? Alzheimer's & dementia (Amsterdam, Netherlands), 1 (3). pp. 380-4. ISSN 2352-8729 DOI: https://doi.org/10.1016/j.dadm.2015.06.003

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/j.dadm.2015.06.003

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar